Efficacy and Safety of Ojeok-San Plus Saengmaek-San for Gastroesophageal Reflux-Induced Chronic Cough: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial.

Front Pharmacol · 2022 · PMC8923584 · PMID 35300295

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Other outcome measures of cough, HRQL, and GI symptoms also showed a positive trend and clinical importance of OJS plus SMS, allowing it to be used in further studies as well.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.